Orphazyme

0 followers


Danish biopharma company, listed on Nasdaq Copenhagen, with a late-stage drug pipeline, developing new treatment options for orphan protein-misfolding diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Anders Fink V.
Chief Executive Officer